Apyx Medical Corporation (NASDAQ:APYX) Q2 2023 Earnings Conference Call August 1, 2023 5:00 PM ET

Company Participants

Charles Goodwin - President & CEO

Tara Semb - CFO

Conference Call Participants

Matt Hewitt - Craig-Hallum Capital Group

George Sellers - Stephens

Frank Takkinen - Lake Street Capital Markets

Operator

Hello, and welcome, ladies and gentlemen, to the Second Quarter of Fiscal 2023 Earnings Conference Call for Apyx Medical Corporation. At this time, all participants have been placed in a listen-only mode. At the end of the company’s prepared remarks, we will conduct a question-and-answer session. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay shortly.

Before we begin, I would like to remind everyone that our remarks and responses to your questions today may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated, including without limitation, those identified in the Risk Factors section of our most recent annual report on Form 10-K, our most recent 10-Q filing and the company's other filings with the Securities and Exchange Commission. Such factors may be updated from time to time in our filings with the SEC, which are available on our website. We undertake no obligation to publicly update or revise our forward-looking statements as a result of new information, future events or otherwise.

This call will also include references to certain financial measures that are not calculated in accordance with generally accepted accounting principles or GAAP. We generally refer to these as non-GAAP financial measures. Reconciliations of these non-GAAP financial measures to the most comparable measures calculated and presented in accordance with GAAP are available in the earnings press release on the Investor Relations portion of our website.

I would now like to turn the call over to Mr. Charlie Goodwin, Apyx Medical's President and Chief Executive Officer. Please go ahead, sir.

Charles Goodwin

Thanks, operator, and welcome, everyone to our second quarter of 2023 earnings call. I'm joined on today's call by our Chief Financial Officer, Tara Semb. Let me provide you with a brief outline of what we intend to cover today. I'll begin with a review of our Q2 revenue results and the factors that contributed to our sales performance. Then I'll walk through some of our key operational accomplishments during the quarter. Tara will discuss our financial results in detail along with our 2023 financial guidance, which we reaffirmed in our earnings release today. I'll then provide some closing remarks before we open the call for questions.